TechnologyAI and Autonomy
NVIDIA chips underpin US$3.2B in Chinese AI projects Reuters identified
The tally includes buildings, power systems and planned investment, while NVIDIA's revenue outlook excludes China data centre compute sales.
Summit Therapeutics reports FDA refusal for lung cancer treatment
The agency found the progression-free survival benefit insufficient without statistically significant overall survival gains.
HealthScience and Research
Viking Therapeutics reports lower BMI category in 74% on VK2735
The exploratory VENTURE findings add cardiometabolic measures while weight-loss and tolerability data were previously disclosed.
Analysis
IM Cannabis reports C$1.65M revenue after European operations sale
The company held C$2.356 million in cash at Sept. 30 and is negotiating a non-binding proposal to acquire a controlling stake in a Polish drone business.
Cannabis
TSE: OGIOrganigram gets Nasdaq bid‑price notice with May 2027 deadline
Trading continues on Nasdaq and the TSX as the cannabis producer faces a consecutive-day bid-price test to regain compliance.
HealthStock News
Cerenome reports US$0.7M CNSide revenue with trial data due in 2027
The US$20M facility carries interest and royalties, with future funding conditional ahead of mid-2027 cancer trial readouts.
MiningGold
Asante Gold withdraws guidance as quarterly costs reach US$4,860 an ounce
The Ghana producer faces a Nov. 30 deadline to secure at least US$100 million in new funding and plans a January turnaround update.
Technology
NASDAQ: BTDRThe balance excludes customer deposits, and the weekly post discloses no sale proceeds or average execution price.
Energy
NASDAQ: FRMIThe Financial Times identifies Amazon as the customer, while Fermi says a definitive long-term lease remains under negotiation.
Analysis
Amylyx Pharmaceuticals details 55% hypoglycemia reduction in Phase 3
New controlled event rates expand the avexitide readout, while the company still targets a year-end FDA application.
Latest
Nakamoto extends maturity on 60M USDT of Kraken debt to December 2027
The existing 165 million USDT balance remains due in 2027, while eligible positive net derivatives value can count toward collateral requirements.
AVAX One drops Alberta data-centre plan to focus on AVAX treasury
The Alberta proposal carried an estimated US$30M to US$35M cost, while token revaluation drove the quarterly profit.
USGS projects tungsten capacity growth of at least 10 per cent by 2030
Natural graphite capacity could grow 20 per cent as China retains its dominance and Western tungsten projects face commissioning milestones.
Veolia launches French battery-metals plant with nearly 7,000‑tonne capacity
The Grand Est site will recover cobalt, nickel and copper from black mass, but Veolia disclosed no investment cost or earnings forecast.
GoldHaven Resources reports 8,850 ppm tungsten in Magno rock sample
Selective sampling identified a new skarn target south of Lamb Mountain, but GoldHaven has not dated follow-up work.
Omineca Mining and Metals signs Wingdam gold JV letter with HMI
Omineca would retain a 50 per cent carried interest and receive half the recovered gold at a base cost of C$1,000 an ounce.
Mentioned this week
Mining & Critical Minerals
Gold, silver, uranium, lithium, copper and rare earths: the producers, the developers and the projects behind them.
View all
MiningStock News
Northern Graphite clears US$23.6M debt in Sprott restructuring
The lender becomes its largest shareholder with 9.9 per cent, while the Okanjande stream expands to cover all future production.
Health & Science
Medical and pharmaceutical developments, psychedelics, and the research and safety questions around them.
View all
Health
NASDAQ: TNDMThe new supplies work with existing pumps, with a U.S. launch planned for the first half of 2027 and access limited to pharmacy benefits.
Markets & Technology
Technology, computing, crypto and cannabis, and the listed companies moving in them.
View all
BitcoinCrypto/Blockchain
Twenty One Capital reports US$1.09B bitcoin gain and US$102.8M cash
Convertible-note principal stood at US$486.5 million, with about 16,116 bitcoin pledged as the company evaluates operating businesses.
Technology
NASDAQ: DGXXDigi Power X reports US$12.25M revenue as AI sales reach US$5.66M
Both headline growth rates compare with Q2, while Columbiana billing is expected to start in January 2027.
Energy
Uranium, lithium, oil and gas, hydrogen and the grid: the fuels and the companies behind them.
View all
Uranium
CVE: EUUranium sales costs averaged US$87.22 per pound, while the producer awaits Texas approvals for extraction targets before year-end.
Energy
NYSE: BWXTOPG is reassessing Darlington's first SMR budget and schedule, with its assessment due to be substantially complete by mid-2027.
Energy
NYSE: OKLOPrepayments will help fund U.S. enrichment capacity, with enough HALEU for up to five Aurora powerhouses over multiple years.
Cannabis & Psychedelics
Licensed producers, retail, policy, and the psychedelics companies moving through the clinic.
View all
Cannabis
TSE: LABSInternational medical sales supplied 59 per cent of quarterly revenue, while gross margin and adjusted EBITDA declined sequentially.
Cannabis
TSE: CURACanada and Germany have completed competition reviews, Curaleaf says, while its offer remains outstanding until Dec. 4.
Cannabis
CNSX: CLCThe board accepted its committee's recommendation on Oct. 26, citing the harvest, a stronger outlook and debt repayment.
Psychedelics
NASDAQ: CMPSThe submission draws on studies involving more than 1,000 participants, with a first-half 2027 launch still subject to FDA approval.